Skip to main content
LIFD
OTC Life Sciences

LFTD Partners Reports $5.6M Loss, Going Concern Warning, and $6.6M Inventory Write-Down

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.194
Mkt Cap
$2.876M
52W Low
$0.1
52W High
$1.1
52W Position info
94% above low
Off High info
82% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

LIFD sits 94% above its 52-week low of $0.1 on light trading volume (0.3× avg).

Summary

LFTD Partners posted a $5.6 million six-month loss, recorded a $6.6 million inventory reserve, and warned it may not continue as a going concern due to upcoming federal bans on hemp and kratom products.


Key Events · Earnings and Guidance · LIFD

  • Massive Inventory Write-Down

    Recorded a $6.6 million inventory reserve against hemp-derived ($5.0M) and kratom-derived ($1.4M) inventory due to upcoming federal bans.

  • Going Concern Warning

    Management states substantial doubt about the company's ability to continue as a going concern, citing regulatory threats that could eliminate half or more of revenue.

  • Widening Losses

    Net loss of $5.6 million for the six months ended June 30, 2026, compared to $0.6 million in the prior year period.

  • Cost-Cutting Measures

    Workforce reduced from 100 to 77 employees, expected to save $736,000 annually; Kenosha facility sale expected to close September 16, 2026.


Analysis · LIFD · Life Sciences

The company's core hemp and kratom product lines face federal bans effective November 12, 2026, forcing a $6.6 million inventory reserve and a going concern warning. Management is cutting costs and selling its Kenosha facility, but the regulatory threat could eliminate half or more of revenue.

How filings like this one have moved

In the 30 days to Sep 16, 2026, 40.6% of the 409 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LIFD was trading at $0.19 on OTC in the Life Sciences sector, with a market capitalization of approximately $2.9M. The 52-week trading range was $0.10 to $1.10. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LIFD - Latest Insights

LIFD
Jul 24, 2026, 11:14 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.1979
Real-time Price: $0.101 info
Change: -$0.0969 (-49%) info
Market Cap: $1.497M info
LIFD
Jun 30, 2026, 6:44 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.162638
Real-time Price: $0.101 info
Change: -$0.061638 (-38%) info
Market Cap: $1.497M info
LIFD
May 14, 2026, 5:42 PM EDT
Filing Type: 10-Q
Importance Score:
10
Price at Filing: $0.180
Real-time Price: $0.101 info
Change: -$0.079 (-44%) info
Market Cap: $1.497M info
LIFD
Mar 31, 2026, 8:17 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.240
Real-time Price: $0.101 info
Change: -$0.139 (-58%) info
Market Cap: $1.497M info